Nkarta (NKTX) Non Operating Income (2019 - 2026)
Nkarta's (NKTX) quarterly Non Operating Income came in at $3.0 million in Q1 2026, down 33.55% year-on-year from $4.6 million in Q1 2025, and down 14.3% quarter-over-quarter from $3.6 million in Q4 2025.
Nkarta (NKTX) Non Operating Income (2019 - 2026) Analysis & Trends
Nkarta's Non Operating Income history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 33.55% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $16.4 million, a 21.05% decrease from a year earlier, with the FY2025 full-year figure at $17.9 million, down 7.68% from the prior year.
- Non Operating Income slipped to $3.0 million in Q1 2026 per NKTX's latest filing, from $3.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $5.7 million in Q2 2024 and bottomed at $111000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $3.6 million (2025), against an average of $3.5 million.
- Across the five-year window, Non Operating Income surged 3189.04% in 2022 and tumbled 33.55% in 2026, its largest moves.
- Year by year, Non Operating Income stood at $2.4 million in 2022, then jumped by 42.9% to $3.4 million in 2023, then jumped by 45.38% to $5.0 million in 2024, then slipped by 28.79% to $3.6 million in 2025, then fell by 14.3% to $3.0 million in 2026.
- Per Business Quant, the three latest NKTX Non Operating Income figures stand at $3.0 million (Q1 2026), $3.6 million (Q4 2025), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 4.58 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 5.72 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 3.57 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 689,000.00 |
| Mar 31, 2022 | 111,000.00 |
| Dec 31, 2021 | 73,000.00 |
| Sep 30, 2021 | 75,000.00 |
| Jun 30, 2021 | 99,000.00 |